Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Baxter
Mallinckrodt
McKinsey
AstraZeneca

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Bicine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Bicine: Patents, clinical trial progress, indications

Bicine is an investigational drug.

There have been 33 clinical trials for Bicine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2010.

The most common disease conditions in clinical trials are Breast Neoplasms, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are Gruppo Italiano Malattie EMatologiche dell'Adulto, Assistance Publique - Hôpitaux de Paris, and Sanofi.

There is one US patent protecting this investigational drug and fifteen international patents.

Recent Clinical Trials for Bicine
TitleSponsorPhase
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML PatientsChangzhou No.2 People's HospitalPhase 3
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML PatientsHuai'an Second People's HospitalPhase 3
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML PatientsJingjiang People's HospitalPhase 3

See all Bicine clinical trials

Clinical Trial Summary for Bicine

Top disease conditions for Bicine
Top clinical trial sponsors for Bicine

See all Bicine clinical trials

US Patents for Bicine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Bicine   Start Trial Double-acylated GLP-1 derivatives Novo Nordisk A/S (Bagsvaerd, DK)   Start Trial
Bicine   Start Trial Measurement method for human pancreatic lipase activity ASAHI KASEI PHARMA CORPORATION (Tokyo, JP)   Start Trial
Bicine   Start Trial Isolation of polymerase-nucleic acid complexes Pacific Biosciences of California, Inc. (Menlo Park, CA)   Start Trial
Bicine   Start Trial Dental implant coated with a mixed solution of chemical buffering agent and organic amphiphilic substance and a preparation process thereof OSSTEMIMPLANT CO., LTD (Seoul, KR)   Start Trial
Bicine   Start Trial Malodor neutralizing composition   Start Trial
Bicine   Start Trial Trabecular meshwork stem cells University of Pittsburgh--of the Commonwealth System of Higher Education (Pittsburgh, PA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Bicine

Drugname Country Document Number Estimated Expiration Related US Patent
Bicine China 104519902 2032-05-08   Start Trial
Bicine European Patent Office 2846823 2032-05-08   Start Trial
Bicine Japan 2015517477 2032-05-08   Start Trial
Bicine Japan 6250034 2032-05-08   Start Trial
Bicine World Intellectual Property Organization (WIPO) 2013167454 2032-05-08   Start Trial
Bicine China 105164273 2033-04-18   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Mallinckrodt
McKesson
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.